Recruiting studies: Shock Hemorrhagic

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Early Initiated Vasopressor Therapy in the Emergency Department
Phase 3 · 8 location(s) · Odense University Hospital · NCT05931601 Renal Perfusion and the Development of AKI Following Traumatic Injury
Phase N/A · 1 location(s) · King's College Hospital NHS Trust · NCT06917053 Implementation of an Empiric Transfusion Bundle for Out of Hospital Patients With Haemorrhagic Shock
Phase N/A · 1 location(s) · Medical University of Graz · NCT06891131 Trauma Resuscitation With Low-Titer Group O Whole Blood or Products
Phase 3 · 13 location(s) · University of Alabama at Birmingham · NCT05638581 Metabolic Reprogramming in Renal Tubular Cells in Acute Kidney Injury Following Severe Trauma
Phase N/A · 2 location(s) · Assistance Publique - Hôpitaux de Paris · NCT06167512 Evaluation of Endothelial Glycocalyx in the Surgical Resuscitation of Major Burn Patients
Phase N/A · 1 location(s) · Hospital Universitari Vall d'Hebron Research Institute · NCT06670248 REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
NA · 2 location(s) · Arsenal Medical, Inc. · NCT02880163 Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413 Fibrinogen Early In Severe Trauma StudY II
Phase 3 · 24 location(s) · Australian and New Zealand Intensive Care Research Centre · NCT05449834 Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children
Phase 3 · 23 location(s) · Philip Spinella · NCT06070350 Outpatient and Intermittent Dosing of Elranatamab in Relapsed/Refractory Multiple Myeloma
Phase 2 · 6 location(s) · Ontario Clinical Oncology Group (OCOG) · NCT06421675 Infliximab for Cytokine Release Syndrome Prophylaxis During Teclistamab or Talquetamab Therapy in Patients With Relapsed
Phase 2 · 1 location(s) · Naresh Bumma · NCT07657312 Whole Blood in Trauma Patients With Hemorrhagic Shock
Phase 3 · 1 location(s) · Fundacion Clinica Valle del Lili · NCT05634109 Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Phase 2 · 17 location(s) · SCRI Development Innovations, LLC · NCT05972135 Comparison of Early Proton Pump Inhibitor Initiation Versus Usual Care on Acute Kidney Injury in Hemorrhagic Shock Patie
Phase 2/Phase 3 · 1 location(s) · The University of Texas Health Science Center, Houston · NCT06531642 CAlcium and VAsopressin Following Injury Early Resuscitation (CAVALIER) Trial
Phase 2 · 15 location(s) · Jason Sperry · NCT05958342

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.